NCT03198637View on ClinicalTrials.gov

Comparison of Neuromuscular Blockade's Monitoring and Clinical Assessment During Cisatracurium Paralysis in Critically Ill Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

May 31, 2018

Study Completion Date

May 31, 2018

Conditions
Critical Illness
Interventions
DRUG

Cisatracurium's monitoring by TOF (train-of-four) WATCH device.

Neuromuscular blockade's monitoring by Cisatracurium thanks to TOF (train-of-four) WATCH device.

DRUG

clinical assessment

Trial Locations (1)

86021

CHU de Poitiers, Poitiers

All Listed Sponsors
lead

Poitiers University Hospital

OTHER

NCT03198637 - Comparison of Neuromuscular Blockade's Monitoring and Clinical Assessment During Cisatracurium Paralysis in Critically Ill Patients | Biotech Hunter | Biotech Hunter